ABSTRACT
A widely shared conception is that, unlike other risks, the distribution of ‘genetic risks’ among humans does not follow the lines of other social and economical classifications.1 This idea is probably one of the reasons why obvious questions of prioritisation are rarely raised at the political level, and why large public support has been unconditionally granted to the Human Genome Project and other subsequent human genetic and genomic research projects, despite the lack of guarantee that the fruits of that hi-tech research will be universally available to all humankind.
